Sign up for the Trade of the Day App

[ADVERTISEMENT]

Wakeup Watchlist Content
Left For Dead a Year Ago. Now It Cannot Stop Making Money.
Most biotechs burn cash and beg for more. This one is printing it. Liquidia (LQDA) spen...
I’m not rushing into the SpaceX IPO
The biggest IPO in history hits Friday. Here's why I'm in no rush to touch it.
Wakeup Watchlist Content
The Biotech Everyone Gave Up On Is Quietly Rebuilding
Biogen’s (BIIB) biggest drugs are dying. The stock is climbing anyway. For a comp...
SpaceX Isn’t the Only Big Deal This Week
Two massive events this week could present ample opportunity for smart traders who know...

[ADVERTISEMENT]

Wakeup Watchlist Content
The Company Nvidia Paid $2 Billion to Lock Up
Publisher’s Note: Karim’s Tracking Another Shadow Move — Live Session Today Karim...
The Most Famous “Insider Buy” On Wall Street Is A Myth
A real insider buy means a CEO is betting on what he knows about his own business. Mich...
Wakeup Watchlist Content
The Chart Said It, The Insiders Confirmed It
When I wrote about Electronic Arts (EA) last Monday, I told you the chart was whisperin...
Where There’s Panic, There’s Profit (If You Can Spot the Difference)
In March 2020, when buying felt insane, I told readers to buy Marvell at $22. It just c...

[ADVERTISEMENT]

Follow the Smart Money
Institutions and hedge funds don’t broadcast their moves on TV, but they do leave clues...
Wakeup Watchlist Content
They Built the First Real Alzheimer’s Drug.
Biogen (BIIB) developed the first real Alzheimer’s drug, a breakthrough the indus...